Navigation Links
Successful Diabetes Product Launches Balance Digital & Traditional Public Relations Tools
Date:1/4/2012

CHAPEL HILL, N.C., Jan. 4, 2012 /PRNewswire/ -- Successfully launching a new diabetes product in this digital age still relies heavily on traditional public relations tools, namely press releases, media interviews, health fairs, and educational pamphlets. However, introducing new technologies into a launch plan is an effective way to inform patients and physicians of the new product.

Among the most effective technologies for reaching patients and physicians about a new diabetes product are online advocacy groups, branded web sites, and e-newsletters, according to commercial executives who participated in primary research on "Educating the Marketplace to Support Successful Diabetes Product Launches" conducted by Best Practices, LLC. Podcasts are one of the least effective technologies for informing patients, but achieve some success in reaching physicians.

Download a complimentary white paper at http://www3.best-in-class.com/rr1139.htm that includes selected best practices drawn from extensive primary research with executives from 26 leading companies.

Key insights from other areas of the research include:

  • 89% of companies start engaging thought leaders and key investigators in clinical trial protocol development at Phase II or before. The largest response groups signaled Phase II as the kickoff to most thought leader services.
  • Engaging thought leaders and key investigators in clinical trial protocol development is rated by 94% of companies as one of the most important thought leader education activities.

"Educating the Marketplace to Support Successful Diabetes Product Launches," a primary research study conducted by Best Practices, LLC, is a 161-page report with more than 450 benchmark metrics and 41 executi
'/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Announces Successful Results From Phase III Onychomycosis Trials
2. Successful ILM-Blue Patent Opposition Proceedings Before the European Patent Office; Patent Validity Confirmed
3. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
4. Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
5. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
6. GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety
7. NephroGenex Announces the Successful Completion of PYR-210
8. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
9. Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
10. Market Education Tactics and Strategies to Support Successful Oncology Product Launches
11. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014   Auxilium Pharmaceuticals ... integrated specialty biopharmaceutical company, today announced that the Company ... on Thursday, August 7, 2014 before the opening of ... a conference call that day at 8:30 a.m. ET ... of 2014. The presentation slides to be used during ...
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
(Date:7/31/2014)... 31, 2014 The vineyards are lush, and ... harvest. And, to celebrate, folks are gearing up for the ... 6 and 7, 2014 along the Leelanau Peninsula Wine ... walk or run through the vineyards start-ing at 9:00 a.m. ... A unique course between rows of grapevines offers an experience ...
(Date:7/31/2014)... United Theological Seminary is pleased to welcome ... and Peter J. Bellini. Both began their teaching duties ... a Director of Non-Degree Programs, Mark Abbott, who begins ... Donne, Assistant Professor of New Testament, received a Ph.D. ... Second Temple Judaism, and Greek courses. His research interests ...
(Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... Guinness International Champions Cup Finals tickets at the Sun ... 2014 Guinness International Champions Cup is now underway. Residents and ... to be able to watch the Guinness International Champions Cup ... The eight teams competing in the tournament have been split ...
(Date:7/31/2014)... Denver, Colorado (PRWEB) July 31, 2014 ... commonly doctors recommend pain killers for this health problem. ... reveals that this new program was created by Peter ... purpose to help sufferers from all over the world ... , If people wish to view pros and ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Andrie, Inc. V. ... , The Michigan Supreme Court has made the determination that ... use tax when the taxpayer was unable to prove during ... purchases. The Court reversed the Court of Appeals decision on ... the use tax exemption for purchases from Michigan sellers. The ...
Breaking Medicine News(10 mins):Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Growing Seminary Welcomes New Faculty 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 3Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3
... another bout of West Nile, a potentially fatal, mosquito-spread infection. ... Control of the Harris county has said that the situation ... is still a large percentage of people in Houston who ... repellants or going out at night in short-sleeve shirts can ...
... out with the report that with UK leading the group, cancer ... use of new drugs. ,The study termed uptake of ... as well as in New Zealand, Poland, Czech Republic and South ... US were leaders in using new cancer drugs. ,The ...
... forty per cent (37 per cent) of British women and a ... unattractive on holiday as a result of excessive exposure to the ... has been conducted to highlight Sun Awareness Week, which kicks off ... over unsightly sunburn has meant that one in three Brits could ...
... eyes, say experts, who advise frequent short breaks every half ... ,Studies have shown that eyestrain and other vision problems ... people using video display terminals at work, said Kerry Beebe, ... ,The most common symptoms are eyestrain, blurred vision, ...
... the brakes on a racing heartbeat. ... the May 11 issue of Circulation Research how an enzyme ... of the heart's "fight-or-flight" reaction to adrenaline. ,A ... setting the pace of the beating heart, triggering its neighbor ...
... who is on a visit to the US, has ... in Hyderabad, promising to provide all necessary infrastructure. ... the signing of an MoU between Stanford University, the ... Research Institute) in California Thursday. ,Under the ...
Cached Medicine News:Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Britains Complacent Attitude To Uptake Of New Cancer Drugs Revealed 2Health News:Burnt Brits Don't Feel Hot 2Health News:Many Hours on Computer may Harm Eyes 2Health News:Slowing the Racing Heart 2Health News:Reddy Asks Stanford University to Open Hyderabad Campus 2
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: